...
首页> 外文期刊>Expert review of proteomics >Proteomics technologies in endometriosis.
【24h】

Proteomics technologies in endometriosis.

机译:子宫内膜异位症的蛋白质组学技术。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endometriosis is a common disorder that is associated with infertility and pelvic pain. Diagnosis is based on the visualization of endometriotic lesions during surgery as no reliable serum marker is currently available. The etiology of endometriosis is largely unknown. Over the last 20 years, several proteomics technologies have been used to research novel proteins with a potential etiological role in endometriosis, and to identify candidate serum markers for this condition. While some molecules identified by proteomics technologies may have a relevant role in the pathogenesis of endometriosis, the research of potential serum markers for this condition is still far from any clinical application. This review summarizes the state of the art and potential applications of proteomics in endometriosis research.
机译:子宫内膜异位症是一种常见的疾病,与不孕症和骨盆疼痛有关。诊断基于手术期间子宫内膜异位病变的可视化,因为目前尚无可靠的血清标志物。子宫内膜异位的病因在很大程度上是未知的。在过去的20年中,已经使用了多种蛋白质组学技术来研究在子宫内膜异位症中具有潜在病因作用的新型蛋白质,并确定这种情况的候选血清标志物。尽管通过蛋白质组学技术鉴定的某些分子可能在子宫内膜异位症的发病机理中具有重要作用,但针对这种情况的潜在血清标志物的研究仍远未达到任何临床应用。这篇综述总结了蛋白质组学在子宫内膜异位研究中的最新技术和潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号